{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T19:27:31Z","timestamp":1777836451573,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1385\/mb:31:3:239","type":"journal-article","created":{"date-parts":[[2005,10,17]],"date-time":"2005-10-17T12:52:07Z","timestamp":1129553527000},"page":"239-244","source":"Crossref","is-referenced-by-count":37,"title":["Tumor necrosis factor as a pharmacological target"],"prefix":"10.1007","volume":"31","author":[{"given":"Pietro","family":"Ghezzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Cerami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"313239_CR1","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1126\/science.3895437","volume":"229","author":"B. Beutler","year":"1985","unstructured":"Beutler, B., Milsark, I. W., and & Cerami, A. C. (1985) Passive immunization against cachectin\/tumor necrosis factor protects mice from lethal effect of endotoxin. Science\n                           229, 869\u2013871.","journal-title":"Science"},{"key":"313239_CR2","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/330662a0","volume":"330","author":"K. J. Tracey","year":"1987","unstructured":"Tracey, K. J., Fong, Y., Hesse, D. G., et al. (1987) Anti-cachectin\/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature\n                           330, 662\u2013664.","journal-title":"Nature"},{"key":"313239_CR3","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","volume":"20","author":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference","year":"1992","unstructured":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med.\n                           20, 864\u2013874.","journal-title":"Crit. Care Med."},{"key":"313239_CR4","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1084\/jem.162.6.2163","volume":"162","author":"J. M. Dayer","year":"1985","unstructured":"Dayer, J. M., Beutler, B., and Cerami, A. (1985) Cachectin\/tumor necrosis factor stimulates collage-nase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J. Exp. Med.\n                           162, 2163\u20132168.","journal-title":"J. Exp. Med."},{"key":"313239_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/322547a0","volume":"322","author":"J. Saklatvala","year":"1986","unstructured":"Saklatvala, J. (1986) Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature\n                           322, 547\u2013549.","journal-title":"Nature"},{"key":"313239_CR6","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1084\/jem.167.4.1511","volume":"167","author":"P. Seckinger","year":"1988","unstructured":"Seckinger, P., Isaaz, S., and Dayer, J. M. (1988) A human inhibitor of tumor necrosis factor alpha. J. Exp. Med.\n                           167, 1511\u20131516.","journal-title":"J. Exp. Med."},{"key":"313239_CR7","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1073\/pnas.87.13.5188","volume":"87","author":"P. Seckinger","year":"1990","unstructured":"Seckinger, P., Zhang, J. H., Hauptmann, B., and Dayer, J. M. (1990) Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor. Proc. Natl. Acad. Sci. USA\n                           87, 5188\u20135192.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"313239_CR8","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0021-9258(19)40049-5","volume":"265","author":"H. Engelmann","year":"1990","unstructured":"Engelmann, H., Novick, D., and Wallach, D. (1990) Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J. Biol. Chem.\n                           265, 1531\u20131536.","journal-title":"J. Biol. Chem."},{"key":"313239_CR9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1126\/science.3754653","volume":"232","author":"B. Beutler","year":"1986","unstructured":"Beutler, B., Krochin, N., Milsark, I. W., Luedke, C., and Cerami, A. (1986) Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science\n                           232, 977\u2013980.","journal-title":"Science"},{"key":"313239_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0014-4827(87)90282-5","volume":"173","author":"N. Busso","year":"1987","unstructured":"Busso, N., Collart, M., Vassalli, J. D., and Belin, D. (1987) Antagonist effect of RU 486 on transcription of glucocorticoid-regulated genes. Exp. Cell Res.\n                           173, 425\u2013430.","journal-title":"Exp. Cell Res."},{"key":"313239_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0014-2999(95)00840-3","volume":"299","author":"E. Di Santo","year":"1996","unstructured":"Di Santo, E., Sironi, M., Mennini, T., et al. (1996) A glucocorticoid receptor-independent mechanism for neurosteroid inhibition of tumor necrosis factor production. Eur. J. Pharmacol.\n                           299, 179\u2013186.","journal-title":"Eur. J. Pharmacol."},{"key":"313239_CR12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1152\/physrev.1944.24.1.89","volume":"24","author":"W. W. Swingle","year":"1944","unstructured":"Swingle, W. W. and Remington, J. W. (1944) Role of adrenal cortex in physiological processes. Physiol. Rev.\n                           24, 89\u2013127.","journal-title":"Physiol. Rev."},{"key":"313239_CR13","first-page":"708","volume":"49","author":"R. S. Abernathy","year":"1957","unstructured":"Abernathy, R. S., Halberg, F., and Spink, W. W. (1957) Studies on mechanism of chloropromazine protection against Brucella endotoxin. J. Lab. Clin. Med.\n                           49, 708\u2013715.","journal-title":"J. Lab. Clin. Med."},{"key":"313239_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0885-4505(86)90108-8","volume":"36","author":"G. Lazar","year":"1986","unstructured":"Lazar, G. and Agarwal, M. K. (1986). The influence of a novel glucocorticoid antagonist on endotoxin lethality in mice strains. Biochem. Med. Metab. Biol.\n                           36, 70\u201374.","journal-title":"Biochem. Med. Metab. Biol."},{"key":"313239_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0014-5793(92)81261-J","volume":"308","author":"G. J. Lazar","year":"1992","unstructured":"Lazar, G. J., Duda, E., and Lazar, G. (1992) Effect of RU 38486 on TNF production and toxicity. FEBS Lett.\n                           308, 137\u2013140.","journal-title":"FEBS Lett."},{"key":"313239_CR16","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1210\/en.132.3.946","volume":"132","author":"R. S. Perlstein","year":"1993","unstructured":"Perlstein, R. S., Whitnall, M. H., Abrams, J. S., Mougey, E. H., and Neta, R. (1993) Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology\n                           132, 946\u2013952.","journal-title":"Endocrinology"},{"key":"313239_CR17","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1016\/S0021-9258(18)60727-6","volume":"263","author":"S. L. Kunkel","year":"1988","unstructured":"Kunkel, S. L., Spengler, M., May, M. A., Spengler, R., Larrick, J., and Remick, D. (1988) Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J. Biol. Chem.\n                           263, 5380\u20135384.","journal-title":"J. Biol. Chem."},{"key":"313239_CR18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/infdis\/163.1.89","volume":"163","author":"G. A. Spinas","year":"1991","unstructured":"Spinas, G. A., Bloeash, D., Keller, U., Zimmerli, W., and Cammisuli, S. (1991) Pretreatment with ibuprofen augments circulating tumor necrosis factor-a, interleukin-6, and elastase during acute endotoxemia. J. Infect. Dis.\n                           163, 89\u201395.","journal-title":"J. Infect. Dis."},{"key":"313239_CR19","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1084\/jem.173.4.1021","volume":"173","author":"G. D. Martich","year":"1991","unstructured":"Martich, G. D., Danner, R. L., Ceska, M., and Suffredini, A. F. (1991) Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents. J. Exp. Med.\n                           173, 1021\u20131024.","journal-title":"J. Exp. Med."},{"key":"313239_CR20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1084\/jem.177.2.547","volume":"177","author":"C. G\u00e9rard","year":"1993","unstructured":"G\u00e9rard, C., Bruyns, C., Marchant, A., et al. (1993) Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med.\n                           177, 547\u2013550.","journal-title":"J. Exp. Med."},{"key":"313239_CR21","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1084\/jem.174.5.1209","volume":"174","author":"R. de Waal-Malefyt","year":"1991","unstructured":"de Waal-Malefyt, R., Abrams, J., Bennet, B., Figdor, C., and de Vries, J. E. (1991) Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med.\n                           174, 1209\u20131220.","journal-title":"J. Exp. Med."},{"key":"313239_CR22","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.4049\/jimmunol.148.6.1725","volume":"148","author":"S. Gautam","year":"1992","unstructured":"Gautam, S., Tebo, J. M., and Hamilton, T. A. (1992) IL-4 suppresses cytokine gene expression induced by IFN-gamma and\/or IL-2 in murine peritoneal macrophages. J. Immunol.\n                           148, 1725\u20131730.","journal-title":"J. Immunol."},{"key":"313239_CR23","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.4049\/jimmunol.151.11.6370","volume":"151","author":"R. de Waal Malefyt","year":"1993","unstructured":"de Waal Malefyt, R., Figdor, C. G., Huijbens, R., et al. (1993) Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J. Immunol.\n                           151, 6370\u20136381.","journal-title":"J. Immunol."},{"key":"313239_CR24","first-page":"5","volume":"13","author":"L. Dumoutier","year":"2002","unstructured":"Dumoutier, L. and Renauld, J. C. (2002) Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions. Eur. Cytokine Netw.\n                           13, 5\u201315.","journal-title":"Eur. Cytokine Netw."},{"key":"313239_CR25","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/35013070","volume":"405","author":"L. V. Borovikova","year":"2000","unstructured":"Borovikova, L. V., Ivanova, S., Zhang, M., et al. (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature\n                           405, 458\u2013462.","journal-title":"Nature"},{"key":"313239_CR26","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nature01321","volume":"420","author":"K. J. Tracey","year":"2002","unstructured":"Tracey, K. J. (2002) The inflammatory reflex. Nature\n                           420, 853\u2013859.","journal-title":"Nature"},{"key":"313239_CR27","doi-asserted-by":"publisher","first-page":"9943","DOI":"10.1073\/pnas.87.24.9943","volume":"87","author":"F. J. Staal","year":"1990","unstructured":"Staal, F. J., Roederer, M., and Herzenberg, L. A. (1990) Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA\n                           87, 9943\u20139947.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"313239_CR28","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.270.5234.286","volume":"270","author":"N. Auphan","year":"1995","unstructured":"Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., and Karin, M. (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science\n                           270, 286\u2013290.","journal-title":"Science"},{"key":"313239_CR29","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1126\/science.8052854","volume":"265","author":"E. Kopp","year":"1994","unstructured":"Kopp, E. and Ghosh, S. (1994) Inhibition of NF-kappa B by sodium salicylate and aspirin. Science\n                           265, 956\u2013959.","journal-title":"Science"},{"key":"313239_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1359-6446(01)01738-X","volume":"6","author":"M. L. Moss","year":"2001","unstructured":"Moss, M. L., White, J. M., Lambert, M. H., and Andrews, R. C. (2001) TACE and other ADAM proteases as targets for drug discovery. Drug Discov. Today\n                           6, 417\u2013426.","journal-title":"Drug Discov. Today"},{"key":"313239_CR31","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1084\/jem.173.3.699","volume":"173","author":"E. P. Sampaio","year":"1991","unstructured":"Sampaio, E. P., Sarno, E. N., Galilly, R., Cohn, Z. A., and Kaplan, G. (1991) Thalidomide selectively inhibts tumor necrosis factor alpha production by stimulated human monocytes. J. Exp. Med.\n                           173, 699\u2013703.","journal-title":"J. Exp. Med."},{"key":"313239_CR32","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","volume":"177","author":"A. L. Moreira","year":"1993","unstructured":"Moreira, A. L., Sampaio, E. P., Zmuidzinas, A., Frindt, P., Smith, K. A., and Kaplan, G. (1993) Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J. Exp. Med.\n                           177, 1675\u20131680.","journal-title":"J. Exp. Med."},{"key":"313239_CR33","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/372739a0","volume":"372","author":"J. C. Lee","year":"1994","unstructured":"Lee, J. C., Laydon, J. T., McDonnell, P. C., et al. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature\n                           372, 739\u2013746.","journal-title":"Nature"},{"key":"313239_CR34","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1084\/jem.183.3.927","volume":"183","author":"M. Bianchi","year":"1996","unstructured":"Bianchi, M., Bloom, O., Raabe, T., et al. (1996) Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J. Exp. Med.\n                           183, 927\u2013936.","journal-title":"J. Exp. Med."},{"key":"313239_CR35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF03401812","volume":"3","author":"P. S. Cohen","year":"1997","unstructured":"Cohen, P. S., Schmidtmayerova, H., Dennis, J., et al. (1997) The critical role of p38 MAP kinase in T cell HIV-1 replication. Mol. Med.\n                           3, 339\u2013346.","journal-title":"Mol. Med."},{"key":"313239_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1053\/gast.2002.30770","volume":"122","author":"D. Hommes","year":"2002","unstructured":"Hommes, D., van den Blink, B., Plasse, T., et al. (2002) Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn\u2019s disease. Gastroenterology\n                           122, 7\u201314.","journal-title":"Gastroenterology"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1385\/MB:31:3:239.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1385\/MB:31:3:239\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1385\/MB:31:3:239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1385\/MB:31:3:239.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T13:31:13Z","timestamp":1744032673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1385\/MB:31:3:239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["313239"],"URL":"https:\/\/doi.org\/10.1385\/mb:31:3:239","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}